by CheckRare Staff | Nov 17, 2023
Rick Hawkins, Chief Executive Officer at Lumos Pharma, discusses treating pediatric growth hormone deficiency (PGHD). Transcription: Most of the patients with pediatric growth hormone deficiency or PGHD, have a moderate form of the disease. They...
by CheckRare Staff | Nov 16, 2023
The FDA has given clearance for a pivotal gastric cancer Phase III trial. Osemitamab (TST001) offers hope for patients with HER2-negative gastric or gastroesophageal adenocarcinoma, a disease with limited treatment options and poor survival rates. By...
by CheckRare Staff | Nov 15, 2023
Pam Vig, PhD, Head of Research and Development at Mirum Pharmaceuticals, discusses Alagille syndrome and progressive familial intrahepatic cholestasis (PFIC). Transcription: I’m Pam Vig, head of Research and Development at Mirum...
by CheckRare Staff | Nov 14, 2023
Rick Hawkins, Chief Executive Officer at Lumos Pharma, discusses the company’s focus on finding a novel treatment for pediatric growth hormone deficiency. Transcription: My name is Rick Hawkins, and I’m the CEO and Chairman of Lumos Pharma....
by CheckRare Staff | Nov 13, 2023
This article explores the significance of this clearance, the potential benefits of KB408, and the path forward for addressing Alpha-1 Antitrypsin Deficiency. Image: Dreamstime In a significant development for the treatment of Alpha-1 Antitrypsin...
